Cargando…

Cost of cardiovascular disease prevention: towards economic evaluations in prevention programs

Detalles Bibliográficos
Autores principales:	Santos, João Vasco, Vandenberghe, Désirée, Lobo, Mariana, Freitas, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210201/ https://www.ncbi.nlm.nih.gov/pubmed/32395556 http://dx.doi.org/10.21037/atm.2020.01.20

Ejemplares similares

Cardiovascular risk assessment: The key path toward precision prevention
por: Li, Jianxin, et al.
Publicado: (2023)

Turning the tide towards cardiovascular prevention
Publicado: (2022)

Economic cost of primary prevention of cardiovascular diseases in Tanzania
por: Ngalesoni, Frida, et al.
Publicado: (2015)

Cardiovascular disease prevention in the health economics era: Clinicians need more than just prescription pads
por: Baum, Seth Joshua
Publicado: (2020)

Prevention is life- and cost-saving
por: Baussano, Iacopo, et al.
Publicado: (2020)

The Pathways to Prevention program: nutrition as prevention for improved cancer outcomes
por: Hiatt, Robert A, et al.
Publicado: (2023)

Rethinking the Goals of Diabetes Prevention Programs
por: Mezuk, Briana, et al.
Publicado: (2021)

Landscapes on Prevention Quality Indicators: A Spatial Analysis of Diabetes Preventable Hospitalizations in Portugal (2016–2017)
por: Ramalho, Andre, et al.
Publicado: (2020)

Is it ‘cancer prevention’ or ‘risk reduction’? #Wordsmatter
por: Walker, Desiree A. H., et al.
Publicado: (2021)

Aspirin for primary prevention of cardiovascular disease in diabetes
por: Xing, Ying, et al.
Publicado: (2019)

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

Prevention of cardiovascular diseases
por: Hobbs, F. D. Richard
Publicado: (2015)

Toward prevention of stroke
por: Thomas, Sanjeev V.
Publicado: (2010)

Cost or revenue: is diabetes prevention doomed due to misalignment of incentives?
por: Mainous 3rd, Arch G, et al.
Publicado: (2020)

Prevention, prevention and prevention
por: Zusman, Shlomo Paul
Publicado: (2019)

The economics of primary prevention of cardiovascular disease – a systematic review of economic evaluations
por: Schwappach, David LB, et al.
Publicado: (2007)

Increasing Hospitalizations for DKA: A Need for Prevention Programs
por: Vellanki, Priyathama, et al.
Publicado: (2018)

Economics of Malaria Prevention in US Travelers to West Africa
por: Adachi, Kenji, et al.
Publicado: (2014)

Cardiovascular prevention model from Kenyan slums to migrants in the Netherlands
por: van de Vijver, Steven, et al.
Publicado: (2015)

Cardiovascular disease prevention: Risk factor modification at the heart of the matter
por: Fawzy, Ameenathul M., et al.
Publicado: (2021)

Moving from the stratification of primary and secondary prevention of cardiovascular risk in diabetes towards a continuum of risk: need for a new paradigm
por: Garcia-Moll, Xavier, et al.
Publicado: (2021)

Prevention of Cardiovascular Burden in COVID-19 Patients Suffering from Familial Hypercholesterolemia: A Global Challenge
por: Vuorio, Alpo, et al.
Publicado: (2021)

Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases
por: Saha, Sanjib, et al.
Publicado: (2010)

Interpretation of the PREVENT study findings on the adjunctive role of intermittent pneumatic compression to prevent venous thromboembolism
por: Kakkos, Stavros K., et al.
Publicado: (2020)

Economic evaluations of fall prevention exercise programs: a systematic review
por: Pinheiro, Marina B, et al.
Publicado: (2022)

One size fits all, or do we have to rethink optimal programming in implantable cardioverter-defibrillators implanted for secondary prevention?
por: Cakulev, Ivan, et al.
Publicado: (2020)

A novel approach to enhance ACL injury prevention programs
por: Gokeler, Alli, et al.
Publicado: (2018)

Solving the Puzzle to Lasting Impact of the National Diabetes Prevention Program
por: Ritchie, Natalie D.
Publicado: (2020)

Towards the prevention of childhood leukemia
por: Nichols, Kim E., et al.
Publicado: (2022)

Strengthening effective preventive services for refugee populations: toward communities of solution
por: Griswold, Kim S., et al.
Publicado: (2018)

Commentary: Evaluating affordability, cost-effectiveness, cost-utility, health economics, and incremental cost-effectiveness ratio of manual small-incision cataract surgery - The need of the hour
por: Tejaswini, Antarvedi, et al.
Publicado: (2022)

A commentary on “Economic evaluation of programs against COVID-19: A systematic review”
por: Ding, Qianqian, et al.
Publicado: (2021)

A commentary on “Economic evaluation of programs against COVID-19: A systematic review”
por: Camargo-Martínez, William, et al.
Publicado: (2021)

Overdose prevention for prisoners in New York: a novel program and collaboration
por: Zucker, Howard, et al.
Publicado: (2015)

At the vanguard: Leaders’ perspectives on establishing healthcare system infection prevention programs
por: Stevens, Michael P., et al.
Publicado: (2022)

Magnesium for the prevention and treatment of cardiovascular disease
por: DiNicolantonio, James J, et al.
Publicado: (2018)

The Evolving Landscape of Cardiovascular Disease Prevention
por: Cainzos-Achirica, Miguel, et al.
Publicado: (2021)

Intracranial Atherosclerosis Disease: A Preventable Epidemic
por: Moonis, Majaz
Publicado: (2020)

When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins
por: Catalá-López, Ferrán, et al.
Publicado: (2013)

Portuguese Primary Healthcare and Prevention Quality Indicators for Diabetes Mellitus – A Data Envelopment Analysis
por: Ramalho, Andre, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r4g0egpuk6f6nt51nvif9070b6